ID

18300

Description

Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00493077

Link

https://clinicaltrials.gov/show/NCT00493077

Keywords

Versions (1)
  1. 10/28/16 10/28/16 -
Uploaded on

October 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Sclerosis NCT00493077

English

Eligibility Multiple Sclerosis NCT00493077

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsing-remitting ms according to poser criteria(cdms or lsdms)30 or ms according to mcdonald criteria
Description

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C0751967
UMLS CUI [2]
C0026769
disability equivalent to an edss of 6.0 or less at screening
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
neutralizing antibody titre > 20 and <500 in two consecutive nab tests. one must be from before screening
Description

Neutralizing Antibodies Titer | Neutralizing Antibodies Tests Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0475463
UMLS CUI [1,2]
C0475208
UMLS CUI [2,1]
C0475463
UMLS CUI [2,2]
C0392366
UMLS CUI [2,3]
C1265611
previous treatment with either subcutaneous administered interferon-b-1b (betaferon®) or interferon-b-1a (rebif tm) prior to enrolment
Description

interferon beta-1b Subcutaneous | Betaferon | Interferon beta-1a Subcutaneous | Rebif

Data type

boolean

Alias
UMLS CUI [1,1]
C0244713
UMLS CUI [1,2]
C1522438
UMLS CUI [2]
C0592527
UMLS CUI [3,1]
C0254119
UMLS CUI [3,2]
C1522438
UMLS CUI [4]
C0752980
a priori has been decided to be treated with avonex
Description

Avonex

Data type

boolean

Alias
UMLS CUI [1]
C0594372
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
is nab positive on avonex
Description

Neutralizing Antibodies Positive Avonex

Data type

boolean

Alias
UMLS CUI [1,1]
C0475463
UMLS CUI [1,2]
C1514241
UMLS CUI [1,3]
C0594372
history of major depression
Description

Major Depressive Disorder

Data type

boolean

Alias
UMLS CUI [1]
C1269683
cardiac insufficiency, cardiomyopathy, significant cardiac dysrhythmia, unstable or advanced ischemic heart disease (nyha iii or iv), or significant hypertension (bp > 180/110 mmhg)
Description

Heart failure | Cardiomyopathies | Cardiac Arrhythmia Significant | Myocardial Ischemia Unstable | Myocardial Ischemia Advanced | New York Heart Association Classification | Hypertensive disease Significant | Blood Pressure

Data type

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C0878544
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C0750502
UMLS CUI [4,1]
C0151744
UMLS CUI [4,2]
C0443343
UMLS CUI [5,1]
C0151744
UMLS CUI [5,2]
C0205179
UMLS CUI [6]
C1275491
UMLS CUI [7,1]
C0020538
UMLS CUI [7,2]
C0750502
UMLS CUI [8]
C0005823
renal insufficiency defined as serum creatinine > 1.5 times the upper normal reference limit
Description

Renal Insufficiency | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
any systemic disease that can influence the patient's safety and compliance, or the evaluation of the disability
Description

Systemic disease Affecting patient safety | Systemic disease Compliance behavior Limited | Systemic disease Affecting Disability Evaluation

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1113679
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C1321605
UMLS CUI [2,3]
C0439801
UMLS CUI [3,1]
C0442893
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0231170
UMLS CUI [3,4]
C1261322
women who are pregnant, breast-feeding or have the possibility for pregnancy during the trial. to avoid pregnancy, women have to be postmenopausal, surgical sterile, sexually inactive or practice reliable contraceptives
Description

Pregnancy | Breast Feeding | Postmenopausal state | Female Sterilization | Sexual Abstinence | Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0232970
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0036899
UMLS CUI [6]
C0700589
Back to the top of the page

Similar models

Eligibility Multiple Sclerosis NCT00493077

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis
Item
relapsing-remitting ms according to poser criteria(cdms or lsdms)30 or ms according to mcdonald criteria
boolean
C0751967 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
EDSS
Item
disability equivalent to an edss of 6.0 or less at screening
boolean
C0451246 (UMLS CUI [1])
Neutralizing Antibodies Titer | Neutralizing Antibodies Tests Quantity
Item
neutralizing antibody titre > 20 and <500 in two consecutive nab tests. one must be from before screening
boolean
C0475463 (UMLS CUI [1,1])
C0475208 (UMLS CUI [1,2])
C0475463 (UMLS CUI [2,1])
C0392366 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
interferon beta-1b Subcutaneous | Betaferon | Interferon beta-1a Subcutaneous | Rebif
Item
previous treatment with either subcutaneous administered interferon-b-1b (betaferon®) or interferon-b-1a (rebif tm) prior to enrolment
boolean
C0244713 (UMLS CUI [1,1])
C1522438 (UMLS CUI [1,2])
C0592527 (UMLS CUI [2])
C0254119 (UMLS CUI [3,1])
C1522438 (UMLS CUI [3,2])
C0752980 (UMLS CUI [4])
Avonex
Item
a priori has been decided to be treated with avonex
boolean
C0594372 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Neutralizing Antibodies Positive Avonex
Item
is nab positive on avonex
boolean
C0475463 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0594372 (UMLS CUI [1,3])
Major Depressive Disorder
Item
history of major depression
boolean
C1269683 (UMLS CUI [1])
Heart failure | Cardiomyopathies | Cardiac Arrhythmia Significant | Myocardial Ischemia Unstable | Myocardial Ischemia Advanced | New York Heart Association Classification | Hypertensive disease Significant | Blood Pressure
Item
cardiac insufficiency, cardiomyopathy, significant cardiac dysrhythmia, unstable or advanced ischemic heart disease (nyha iii or iv), or significant hypertension (bp > 180/110 mmhg)
boolean
C0018801 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0750502 (UMLS CUI [3,2])
C0151744 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0151744 (UMLS CUI [5,1])
C0205179 (UMLS CUI [5,2])
C1275491 (UMLS CUI [6])
C0020538 (UMLS CUI [7,1])
C0750502 (UMLS CUI [7,2])
C0005823 (UMLS CUI [8])
Renal Insufficiency | Creatinine measurement, serum
Item
renal insufficiency defined as serum creatinine > 1.5 times the upper normal reference limit
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Systemic disease Affecting patient safety | Systemic disease Compliance behavior Limited | Systemic disease Affecting Disability Evaluation
Item
any systemic disease that can influence the patient's safety and compliance, or the evaluation of the disability
boolean
C0442893 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C1321605 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0442893 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0231170 (UMLS CUI [3,3])
C1261322 (UMLS CUI [3,4])
Pregnancy | Breast Feeding | Postmenopausal state | Female Sterilization | Sexual Abstinence | Contraceptive methods
Item
women who are pregnant, breast-feeding or have the possibility for pregnancy during the trial. to avoid pregnancy, women have to be postmenopausal, surgical sterile, sexually inactive or practice reliable contraceptives
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
C0700589 (UMLS CUI [6])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial